휴대용 초음파 진단 기기 시장 : 제품 유형, 기술, 용도, 최종 사용자별 - 세계 시장 예측(2026-2032년)

The Portable Ultrasound Devices Market is projected to grow by USD 7.62 billion at a CAGR of 7.75% by 2032.

Portable ultrasound devices are shifting diagnostic imaging from centralized radiology departments to emergency rooms, ambulances, rural clinics, operating rooms, and the patient bedside. The category includes handheld ultrasound systems, laptop-based scanners, cart-light platforms, wireless probes, and point-of-care ultrasound devices that support faster clinical decisions in cardiology, obstetrics, emergency medicine, critical care, musculoskeletal care, vascular access, and primary care.

Demand is supported by aging populations, rising chronic disease burden, clinician adoption of point-of-care ultrasound, and health-system pressure to reduce diagnostic delays and avoid unnecessary patient transfers. Regulatory oversight by agencies such as the U.S. FDA and European authorities, combined with growing reimbursement pathways, credentialing frameworks, and clinical training programs, is strengthening confidence in portable ultrasound devices as a scalable imaging modality.

Transformative Shifts in the Portable Ultrasound Landscape

The portable ultrasound devices market is being reshaped by miniaturized transducers, wireless connectivity, cloud-based image management, improved battery performance, and software-led workflows. Health systems are prioritizing devices that are easy to disinfect, interoperable with electronic health records, compatible with DICOM-based imaging environments, and capable of reliable imaging outside traditional radiology suites.

A major shift is the rise of point-of-care ultrasound as a clinical skill rather than a specialist-only service. Training protocols, tele-ultrasound support, simulation-based education, and automated guidance are expanding usage among emergency physicians, anesthesiologists, intensivists, midwives, nurses, paramedics, and general practitioners, while value-based care models reward faster, lower-cost diagnosis and better triage.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of portable ultrasound by improving image acquisition, interpretation, workflow efficiency, and user confidence. AI-enabled features increasingly support anatomy recognition, automated measurements, ejection fraction estimation, bladder volume calculation, fetal biometry, lung ultrasound scoring, needle guidance, and quality assurance.

The cumulative impact is strongest where specialist access is limited. AI-guided scanning can reduce operator dependency, while edge computing and secure cloud analytics enable faster decision support in emergency, critical care, maternal health, and rural diagnostic settings. However, adoption depends on validated algorithms, transparent performance across diverse populations, cybersecurity controls, regulatory clearance, data privacy compliance, and clinical governance that keeps clinicians accountable for final interpretation.

Key Regional Insights

Asia-Pacific is experiencing strong adoption as China, India, Japan, South Korea, Australia, and ASEAN markets expand hospital infrastructure, maternal health programs, emergency care capacity, and rural diagnostic access. North America remains a technology, clinical training, and reimbursement leader, with the United States and Canada using portable ultrasound devices across emergency medicine, primary care, critical care, cardiology, musculoskeletal care, and home-based care models.

Europe is shaped by EU MDR compliance, public procurement, radiation-free diagnostic preferences, and strong clinician training networks, while Latin America is using portable ultrasound to improve access in urban hospitals, private clinics, mobile care programs, and underserved regions, led by Brazil and Mexico. The Middle East is investing in premium hospital systems, digital health modernization, and emergency preparedness, particularly across GCC countries. Africa shows high unmet need, where rugged, battery-efficient, affordable, and AI-guided portable ultrasound systems can support maternal care, infectious disease assessment, trauma triage, cardiovascular screening, and rural diagnostics.

Key Group Insights

ASEAN markets are adopting portable ultrasound devices through expanding private hospitals, maternal care initiatives, primary care strengthening, and mobile healthcare programs, while GCC countries are emphasizing advanced hospital infrastructure, digital transformation, emergency medicine, and premium point-of-care imaging. The European Union is influenced by harmonized regulatory standards, public-sector purchasing, evidence-based clinical protocols, interoperability requirements, and structured medical education pathways.

BRICS economies represent a large-volume adoption base due to population scale, urbanization, expanding healthcare access, and growing domestic medical technology capabilities, although pricing, reimbursement, and distribution differ widely by country. G7 markets lead in innovation, AI integration, clinical guideline development, safety oversight, and advanced specialist workflows. NATO countries add demand from military medicine, field hospitals, trauma care, humanitarian missions, and disaster-response readiness, where portable ultrasound is valued for speed, mobility, repeatability, and operation in low-resource environments.

Key Country Insights

The United States leads adoption through emergency medicine, critical care, cardiology, obstetrics, anesthesia, and primary care use cases, supported by FDA-cleared systems, expanding point-of-care ultrasound education, and established hospital purchasing pathways. Canada emphasizes access across remote and Indigenous communities, while Mexico and Brazil are growing through hospital modernization, private-sector imaging demand, and broader emergency and maternal care needs. The United Kingdom, Germany, France, Italy, and Spain are shaped by public healthcare procurement, clinician training, EU-aligned quality expectations, and demand for efficient diagnostic pathways, while Russia continues to rely on hospital replacement cycles, regional healthcare investment, and demand for durable imaging platforms.

China is scaling domestic manufacturing, hospital deployment, and digital health integration, while India is driven by affordability, rural diagnostic access, maternal health priorities, and expanding private healthcare networks. Japan prioritizes high-quality imaging, compact design, and aging-population care, Australia uses portable ultrasound across remote medicine, emergency response, and retrieval care, and South Korea combines digital health strength, advanced device manufacturing, and clinician adoption of connected imaging technologies.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated portability rather than compact design alone. Product strategies must emphasize image quality, probe durability, infection control, battery life, cybersecurity, interoperability, usability, and workflows that reduce clinician burden. Manufacturers should build evidence through peer-reviewed studies, real-world performance data, human-factors validation, and post-market surveillance across diverse care settings.

Commercial teams should align offerings with point-of-care ultrasound training, credentialing support, tele-ultrasound enablement, reimbursement education, and service models that fit both tertiary hospitals and resource-constrained clinics. Partnerships with health systems, academic centers, emergency medical services, military and disaster-response teams, and maternal health programs can accelerate adoption and strengthen long-term market positioning.

Research Methodology

The research methodology combines secondary research, regulatory review, product benchmarking, clinical guideline analysis, technology assessment, and expert-informed market assessment. Sources typically include public regulatory databases, product clearances, healthcare policy documents, reimbursement references, peer-reviewed literature, procurement trends, clinical society guidance, and publicly available data from recognized health authorities.

Market interpretation is strengthened through triangulation across demand indicators, technology adoption signals, regional healthcare spending patterns, installed-base dynamics, training ecosystem development, regulatory activity, and competitive developments. This approach helps separate durable market drivers from short-term promotional claims and supports evidence-based evaluation of portable ultrasound devices, AI-enabled workflows, and point-of-care ultrasound adoption without relying on unverified projections.

Conclusion

Portable ultrasound devices are becoming a core component of decentralized diagnostics, enabling faster imaging decisions in hospitals, clinics, emergency response, ambulatory care, and community health settings. Their value proposition is strongest where mobility, speed, affordability, safety, and repeatable bedside assessment improve patient management and reduce diagnostic delays.

The next phase of competition will be defined by AI-assisted usability, connected imaging ecosystems, clinical evidence, regulatory trust, cybersecurity, and service models that support broad user adoption. Organizations that combine high-quality imaging with training, interoperability, workflow integration, and validated decision-support tools will be best positioned to strengthen their role in the global portable ultrasound devices landscape.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Portable Ultrasound Devices Market, by Product Type

• 7.1. Cart Based
• 7.2. Handheld

8. Portable Ultrasound Devices Market, by Technology

• 8.1. 2D
• 8.2. 3D/4D
• 8.3. Doppler
  • 8.3.1. Color Doppler
  • 8.3.2. Power Doppler
  • 8.3.3. Spectral Doppler
• 8.4. Elastography

9. Portable Ultrasound Devices Market, by Application

• 9.1. Abdominal
  • 9.1.1. Kidney
  • 9.1.2. Liver
  • 9.1.3. Pancreas
• 9.2. Cardiology
  • 9.2.1. Adult Cardiology
  • 9.2.2. Pediatric Cardiology
• 9.3. Musculoskeletal
  • 9.3.1. Joint Imaging
  • 9.3.2. Sports Medicine
  • 9.3.3. Tendon Imaging
• 9.4. Obstetrics & Gynecology
• 9.5. Vascular
  • 9.5.1. Carotid Vascular
  • 9.5.2. Peripheral Vascular
  • 9.5.3. Renal Vascular

10. Portable Ultrasound Devices Market, by End User

• 10.1. Ambulatory Care
• 10.2. Clinics
• 10.3. Home Care
• 10.4. Hospitals

11. Portable Ultrasound Devices Market, by Region

• 11.1. Asia-Pacific
• 11.2. North America
• 11.3. Latin America
• 11.4. Europe
• 11.5. Middle East
• 11.6. Africa

12. Portable Ultrasound Devices Market, by Group

• 12.1. ASEAN
• 12.2. GCC
• 12.3. European Union
• 12.4. BRICS
• 12.5. G7
• 12.6. NATO

13. Portable Ultrasound Devices Market, by Country

• 13.1. United States
• 13.2. Canada
• 13.3. Mexico
• 13.4. Brazil
• 13.5. United Kingdom
• 13.6. Germany
• 13.7. France
• 13.8. Russia
• 13.9. Italy
• 13.10. Spain
• 13.11. China
• 13.12. India
• 13.13. Japan
• 13.14. Australia
• 13.15. South Korea

14. Competitive Landscape

• 14.1. Market Concentration Analysis, 2025
  • 14.1.1. Concentration Ratio (CR)
  • 14.1.2. Herfindahl Hirschman Index (HHI)
• 14.2. Recent Developments & Impact Analysis, 2025
• 14.3. Product Portfolio Analysis, 2025
• 14.4. Benchmarking Analysis, 2025

15. Company Profiles

• 15.1. Analog Devices, Inc.
• 15.2. ARSENAULT DIAGNOSTICS ENTERPRISE INC.
• 15.3. Avante Health Solutions
• 15.4. BenQ Medical Technology Corp.
• 15.5. Butterfly Network, Inc.
• 15.6. Canon Medical Systems Corporation
• 15.7. Cardinal Health
• 15.8. Chison Medical Technologies Co., Ltd.
• 15.9. Clarius Mobile Health Inc.
• 15.10. EchoNous, Inc.
• 15.11. EDAN Instruments, Inc.
• 15.12. Esaote S.p.A.
• 15.13. FUJIFILM Sonosite, Inc.
• 15.14. GE HealthCare Technologies Inc.
• 15.15. Healcerion Co., Ltd.
• 15.16. Henry Schein Medical
• 15.17. ILJIN Group
• 15.18. Konica Minolta Healthcare Americas, Inc.
• 15.19. Koninklijke Philips N.V.
• 15.20. Medline Industries
• 15.21. Mindray Medical International Limited
• 15.22. Murata Manufacturing Co., Ltd.
• 15.23. Palmer Holland
• 15.24. Samsung Medison Co., Ltd.
• 15.25. Siemens Healthineers AG
• 15.26. Sonic Incytes Medical Corp.
• 15.27. Sonoscanner
• 15.28. SonoScape Medical Corp.
• 15.29. TDK Corporation
• 15.30. TE Connectivity
• 15.31. Teratech Corporation
• 15.32. Texas Instruments
• 15.33. Vave Health, Inc.
• 15.34. VINNO Technology (Suzhou) Co., Ltd.